Nebulizer Kit With Mouthpiece

Nebulizer Kit With Mouthpiece Market Outlook

The global nebulizer kit market is projected to reach approximately USD 3.2 billion by 2035, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2025 to 2035. This growth can be largely attributed to the rising prevalence of respiratory diseases, coupled with an increasing awareness regarding effective treatment options among the general population. Factors such as the aging demographic, which tends to have a higher incidence of chronic obstructive pulmonary disease (COPD) and asthma, further bolster demand for nebulizer kits. Additionally, advances in nebulizer technology, including portable and user-friendly devices, are enhancing patient compliance and driving market growth. The shift towards home healthcare solutions is also contributing positively, enabling patients to manage their conditions in the comfort of their homes.

Growth Factor of the Market

The nebulizer kit market is experiencing robust growth due to several key factors. Firstly, the increasing prevalence of chronic respiratory diseases such as asthma, COPD, and cystic fibrosis is significantly propelling the market forward. According to the World Health Organization, around 235 million people suffer from asthma globally, making it a crucial segment for nebulizer kits. Secondly, technological advancements in nebulization devices that offer better efficacy and patient experience are also playing a pivotal role. Innovations such as mesh nebulizers and ultrasonic nebulizers are providing faster and more efficient drug delivery, which is appealing to both healthcare providers and patients. Furthermore, the growing trend towards home-based healthcare and the rising emphasis on self-management of chronic diseases is encouraging patients to invest in nebulizer kits for personal use. Additionally, the expansion of online distribution channels is facilitating easier access to these products, thereby enhancing market growth.

Key Highlights of the Market

• Estimated global market worth around USD 3.2 billion by 2035.
• Projected CAGR of 6.5% from 2025 to 2035.
• Increased prevalence of respiratory diseases fueling demand.
• Technological advancements leading to more efficient nebulizer devices.
• Growing trend toward home healthcare solutions enhancing patient accessibility.

By Product Type

Nebulizer Compressor:

The nebulizer compressor segment is a dominant player in the nebulizer kit market, primarily due to its widespread use in clinical settings and home healthcare. Compressor nebulizers function by converting liquid medication into aerosolized particles that can be inhaled directly into the lungs, delivering effective treatment for respiratory conditions. Their robust performance and ability to handle a variety of medications make them a preferred choice, particularly for patients with chronic respiratory illnesses. The availability of portable compressor models has also boosted their adoption, allowing users to benefit from nebulization therapy even while traveling. Moreover, manufacturers are continually innovating to enhance the efficiency and ease of use of these devices, which is expected to further fuel the growth of this segment. With the increasing prevalence of diseases requiring nebulization therapy, the compressor segment is poised for continued growth in the upcoming years.

Nebulizer Cup:

Nebulizer cups, which hold the medication for nebulization, are essential components of nebulizer kits. The design and efficiency of nebulizer cups are crucial, as they directly impact the effectiveness of drug delivery. Advanced nebulizer cups are designed to minimize medication waste and enhance aerosol generation, which is vital for patient compliance and therapeutic outcomes. The rising awareness among healthcare professionals and patients regarding the importance of high-quality nebulizer cups is fueling the market demand. Furthermore, the introduction of disposable nebulizer cups reduces the risk of cross-contamination and infection, making them increasingly popular in various healthcare settings. The growth of the nebulizer cup segment is further supported by the increasing focus on patient-centered care and the need for efficient respiratory treatment options.

Nebulizer Tubing:

Nebulizer tubing plays a critical role in connecting the nebulizer compressor to the nebulizer cup and facilitating the flow of aerosolized medication to the patient. The demand for high-quality nebulizer tubing is on the rise, driven by advancements in materials and design that improve durability and reduce air resistance. Manufacturers are focusing on producing flexible, kink-resistant tubing that enhances the ease of use and overall efficiency of nebulizer therapy. The growing trend towards home healthcare is also influencing the nebulizer tubing market, as patients require reliable and user-friendly components for effective self-administration. Moreover, the increasing awareness of infection control practices is prompting the development of single-use or easy-to-clean nebulizer tubing options, thereby enhancing market growth. As more patients adopt nebulizer therapy for chronic respiratory conditions, the importance of high-performance nebulizer tubing is expected to grow significantly.

Nebulizer Mask:

Nebulizer masks are an integral part of nebulizer kits, designed to deliver aerosolized medication to the patient effectively. The market for nebulizer masks is expanding due to their crucial role in providing comfort and efficiency during nebulization therapy. These masks come in various sizes, catering to different patient demographics, including pediatrics and adults, which enhances their adaptability in clinical and home settings. Additionally, the introduction of masks that improve fit and reduce leakage is contributing to increased patient satisfaction and compliance. The rising incidence of respiratory diseases and the corresponding need for effective delivery systems are driving the demand for nebulizer masks. As healthcare providers emphasize patient-centered care, the growth of nebulizer masks is expected to continue, further enhancing the overall effectiveness of nebulization therapy.

Nebulizer Mouthpiece:

The nebulizer mouthpiece is a vital component that allows patients to inhale aerosolized medication directly. This segment is gaining traction, particularly among adult patients who prefer mouthpiece delivery for its convenience and effectiveness. Nebulizer mouthpieces are often designed to maximize comfort and minimize medication waste, which is crucial for achieving therapeutic outcomes. The increasing awareness of the importance of effective drug delivery methods is driving the demand for high-quality nebulizer mouthpieces. Additionally, the growing trend towards personalized medicine is encouraging manufacturers to develop mouthpieces that cater to individual patient needs, including tailored sizes and shapes. With the surge in respiratory ailments and the emphasis on efficient nebulization therapy, the nebulizer mouthpiece segment is poised for substantial growth in the forthcoming years.

By Application

COPD:

The application segment for COPD is one of the largest in the nebulizer kit market, primarily due to the increasing prevalence of chronic obstructive pulmonary disease worldwide. COPD is a progressive disease that severely impairs airflow, making it essential for patients to receive effective treatment through nebulization therapy. The use of nebulizers allows for the direct delivery of bronchodilators and corticosteroids into the lungs, providing rapid relief from symptoms and improving quality of life. The rising awareness and diagnosis of COPD are driving demand within this application segment, as more patients seek effective management solutions. Furthermore, the growth of telemedicine and remote patient monitoring is facilitating better access to nebulization therapy, thereby bolstering this segment’s growth. With an aging population and the associated rise in respiratory diseases, the COPD application segment is expected to continue its upward trajectory throughout the forecast period.

Asthma:

The asthma application segment is another significant contributor to the nebulizer kit market, driven by the global increase in asthma prevalence, particularly among children and young adults. Asthma attacks can lead to severe respiratory distress, necessitating prompt and effective treatment with nebulized medication. Nebulization therapy is especially beneficial for patients who may struggle with traditional inhalers, such as young children or those with severe asthma. The ability to deliver medication in a fine mist enhances the likelihood of medication reaching the lungs effectively, making nebulizers a preferred option in acute asthma management. Additionally, advancements in nebulizer technology that allow for easier use and portability are further encouraging patients to adopt nebulization therapy for asthma management. As awareness of asthma increases, the nebulizer kit market is poised to see continued growth in this application segment.

Cystic Fibrosis:

The cystic fibrosis application segment is vital in the nebulizer kit market, as patients with this genetic disorder require consistent and effective respiratory therapy to manage their condition. Nebulizers are commonly used to administer medication that helps in clearing mucus from the lungs and improving respiratory function. The increasing incidence of cystic fibrosis, combined with advancements in nebulization technologies that enhance drug delivery efficacy, is driving the growth of this segment. Cystic fibrosis treatment often involves a combination of medications, and nebulizers facilitate the simultaneous delivery of multiple drugs, making them an essential tool for patient management. As awareness and diagnosis of cystic fibrosis continue to rise, the demand for nebulizer kits tailored specifically for these patients is expected to grow significantly over the forecast period.

Respiratory Infections:

The respiratory infections application segment is gaining traction in the nebulizer kit market, driven by the increasing number of cases of pneumonia, bronchitis, and other respiratory infections. Nebulizers play a crucial role in delivering antibiotics and other medications directly to the lungs in a highly effective manner. The rising awareness regarding the benefits of nebulization therapy for treating respiratory infections, especially in pediatric populations, is propelling demand in this segment. Furthermore, the COVID-19 pandemic has heightened awareness of respiratory health and the importance of effective treatment options, leading to increased investments in nebulization therapy. As healthcare providers and patients recognize the advantages of nebulization for managing respiratory infections, this application segment is poised for substantial growth in the coming years.

Others:

The "Others" application segment encompasses various respiratory issues that may require nebulization therapy, including allergic reactions, bronchospasm, and certain pulmonary disorders that are less common but still necessitate effective treatment. This segment's growth is fueled by the broadening understanding of nebulization therapy's versatility and its ability to cater to a diverse range of respiratory conditions. The increasing emphasis on personalized medicine and patient-centered care is leading to the development of nebulization protocols tailored to individual needs, encompassing a wider array of applications. Additionally, as more patients seek alternative treatments for mild respiratory conditions, the nebulization therapy market for various other applications is expected to expand. This growth reflects the rising trend towards comprehensive respiratory care, enhancing the demand for nebulizer kits across various medical contexts.

By Distribution Channel

Hospitals & Clinics:

The hospitals and clinics distribution channel represents a significant share of the nebulizer kit market, as these institutions are primary providers of respiratory care. The demand for nebulizers in hospitals stems from the need for immediate and effective treatment for patients with acute respiratory conditions. Hospitals utilize nebulizers for both inpatients and outpatients, ensuring that medication is administered efficiently and effectively. The growing prevalence of respiratory diseases has driven hospitals to invest in high-quality nebulizer kits to improve patient outcomes. Additionally, the emphasis on evidence-based practice and clinical guidelines that advocate for nebulization therapy further supports the growth of this distribution channel. As healthcare systems continue to prioritize respiratory care, the hospitals and clinics segment is expected to maintain a strong presence in the nebulizer kit market.

Retail Pharmacies:

Retail pharmacies are increasingly becoming a key distribution channel for nebulizer kits, driven by the rising demand for over-the-counter respiratory health solutions. Patients seeking to manage chronic respiratory conditions are turning to pharmacies for convenient access to nebulizer kits and related products. The availability of various nebulizer models and accessories in retail settings provides consumers with a wide range of options tailored to their needs. Moreover, the growing trend of self-care and the shift towards home healthcare solutions are encouraging more patients to purchase nebulizer kits directly from pharmacies. Retail pharmacies also play a crucial role in educating patients about the proper use of nebulizers and their benefits, further enhancing consumer confidence. As the market continues to evolve, retail pharmacies are expected to expand their offerings in nebulization therapy, driving growth in this distribution channel.

Online Stores:

The online stores distribution channel is rapidly gaining traction in the nebulizer kit market, as e-commerce continues to transform the way consumers access healthcare products. The convenience of online shopping and the vast selection of nebulizer kits available through various digital platforms are appealing to patients seeking respiratory solutions. Online stores offer competitive pricing, allowing consumers to compare products and make informed choices. Additionally, the COVID-19 pandemic has accelerated the shift towards online shopping for healthcare products, as patients prefer to minimize in-person visits to pharmacies or clinics. The growing emphasis on direct-to-consumer sales is also enabling manufacturers to reach a broader audience, further boosting the online segment. As e-commerce continues to evolve, the online stores distribution channel is expected to play a pivotal role in the growth of the nebulizer kit market.

Home Healthcare:

The home healthcare distribution channel is becoming increasingly vital in the nebulizer kit market, driven by the growing trend of patients managing chronic respiratory conditions at home. The convenience of having nebulizers available for self-administration allows patients greater autonomy in their health management. With advancements in nebulizer technology making devices more portable and user-friendly, patients are more inclined to adopt home nebulization therapy. Furthermore, the emphasis on reducing hospital visits and promoting home-based care is propelling the demand for nebulizer kits in this segment. The rising awareness of the importance of respiratory health and the efficacy of at-home treatments are driving the growth of the home healthcare distribution channel. As more patients seek to manage their conditions in the comfort of their homes, this segment is expected to experience significant expansion in the coming years.

Regional Outlook

The nebulizer kit market shows varying dynamics across different regions, influenced by factors such as healthcare infrastructure, prevalence of respiratory diseases, and patient preferences. In North America, the market is projected to hold a significant share due to the higher prevalence of chronic respiratory conditions and a well-established healthcare system. The region's market is expected to grow at a CAGR of approximately 6% during the forecast period, driven by advancements in nebulization technology and increasing consumer awareness of respiratory health. Meanwhile, Europe is also witnessing steady growth, fueled by the increasing focus on patient-centered healthcare and robust regulatory frameworks that promote the use of nebulization therapy for respiratory conditions. The presence of leading nebulizer manufacturers in the region further strengthens its market position.

In the Asia Pacific region, the nebulizer kit market is expected to experience the highest growth rate, with a CAGR exceeding 7% during the forecast period. This growth can be attributed to the rising air pollution levels, which contribute to respiratory diseases, as well as an increasing aging population that necessitates effective treatment options. Moreover, the expansion of healthcare access in developing economies within the region is further driving demand for nebulizer kits. Latin America and the Middle East & Africa are also expected to contribute to market growth, albeit at a slower pace due to varying healthcare infrastructure and economic conditions. However, increasing awareness of respiratory health and the establishment of healthcare initiatives to address respiratory diseases are anticipated to stimulate growth in these regions as well. Overall, the regional outlook for the nebulizer kit market is optimistic, with each region presenting its unique opportunities and challenges.

Opportunities

The nebulizer kit market is rife with opportunities that stakeholders can leverage to enhance growth and profitability. One of the most significant opportunities lies in the continuous advancements in technology, which are improving the efficiency and ease of use of nebulizers. Manufacturers are innovating with new features such as smart nebulizers that provide real-time feedback on medication delivery and adherence, making them appealing to both healthcare providers and patients. Additionally, the development of portable and battery-operated nebulizers is expanding the market by catering to the needs of users who require mobility and convenience. The increasing adoption of telehealth services further complements this trend, as patients can receive consultations and prescriptions remotely, enhancing the overall accessibility of nebulization therapy. Furthermore, as awareness regarding respiratory health continues to grow, there is significant potential for the introduction of new products and services that cater to specialized respiratory conditions, creating avenues for growth in niche markets.

Another promising opportunity is the focus on global health initiatives aimed at addressing respiratory diseases, particularly in developing regions. Governments and non-governmental organizations are increasingly prioritizing respiratory health, creating funding and resource allocation aimed at improving healthcare infrastructure. This can lead to increased access to nebulizer kits in underserved areas, thus driving market growth. There is also a growing demand for education and training regarding the correct use of nebulizers, presenting opportunities for manufacturers to engage in awareness campaigns and provide educational resources. By collaborating with healthcare providers to enhance patient understanding, companies can foster greater product adoption. Ultimately, the convergence of technology, health initiatives, and education presents significant growth opportunities for the nebulizer kit market that stakeholders can capitalize on in the coming years.

Threats

Despite the promising growth prospects, the nebulizer kit market faces several threats that could impede its progress. One of the primary challenges is the competition from alternative therapies and treatment options, such as metered-dose inhalers (MDIs) and dry powder inhalers (DPIs). These alternatives often offer convenience, portability, and ease of use, which may lead some patients to prefer them over nebulizers, particularly for mild to moderate conditions. Additionally, the increasing number of generic products in the market can drive down prices and reduce profit margins for established manufacturers. This price competition may affect the overall market dynamics, particularly in regions where cost is a major consideration in healthcare purchasing decisions. Furthermore, regulatory challenges and compliance requirements related to the approval and marketing of nebulizers and associated products can pose significant hurdles for manufacturers, particularly smaller companies lacking the resources to navigate complex regulatory landscapes effectively.

Another notable threat stems from the economic fluctuations that can impact healthcare spending. In times of economic downturn, healthcare budgets may be slashed, affecting both institutional purchasing and individual consumer spending on medical devices such as nebulizer kits. Additionally, the market is also susceptible to supply chain disruptions, as seen during the COVID-19 pandemic, which highlighted vulnerabilities in the global supply chain for medical devices. These disruptions can lead to product shortages, delays in manufacturing, and increased costs, all of which can negatively impact market growth. As a result, stakeholders in the nebulizer kit market must remain vigilant in addressing these threats proactively and consider strategic initiatives to mitigate potential risks while capitalizing on emerging opportunities.

Competitor Outlook

• Philips Healthcare
• Omron Healthcare
• Drive DeVilbiss Healthcare
• PARI Respiratory Equipment
• DeVilbiss Healthcare
• Medtronic
• Invacare Corporation
• Sunrise Medical
• Rudolf Riester GmbH
• Trudell Medical International
• Altera Health
• Welch Allyn
• Fisher & Paykel Healthcare
• CareFusion Corporation
• ResMed

The competitive landscape of the nebulizer kit market is characterized by a mix of established players and emerging companies, all vying for market share in a growing industry. Key manufacturers such as Philips Healthcare and Omron Healthcare are leading the charge, thanks to their innovative product offerings and strong brand recognition. Philips Healthcare, for instance, has a long-standing reputation for producing high-quality nebulization devices, while Omron Healthcare's focus on user-friendly designs and advanced technology has allowed it to capture a significant market share. The competition within this landscape is intensified by the rapid pace of technological advancements, with players consistently striving to develop more efficient, portable, and cost-effective nebulizers that cater to diverse patient needs.

Additionally, companies like Drive DeVilbiss Healthcare and PARI Respiratory Equipment are noteworthy contenders in the market, known for their robust portfolio of nebulization devices and accessories. Drive DeVilbiss is recognized for its commitment to innovation, while PARI has a strong focus on providing specialized solutions for various respiratory conditions. The presence of these players underscores the competitive nature of the nebulizer kit market, as they continually adapt to changing market dynamics and consumer preferences. Moreover, the rise of online retail platforms has encouraged these companies to enhance their digital presence, enabling them to reach a broader audience and facilitate easier access to their products.

Emerging companies and startups are also making their mark in the nebulizer kit market, capitalizing on niche segments and innovative technologies. For example, Trudell Medical International and Altera Health are notable players focusing on developing advanced nebulization solutions tailored to specific patient demographics. These companies are often agile and can quickly adapt to market trends, allowing them to introduce unique offerings that address specific patient needs. As the nebulizer kit market continues to evolve, these emerging players are expected to contribute significantly to the overall competitive landscape, fostering a spirit of innovation and driving growth.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 ResMed
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Welch Allyn
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Altera Health
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Sunrise Medical
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Omron Healthcare
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Philips Healthcare
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Rudolf Riester GmbH
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 DeVilbiss Healthcare
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Invacare Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 CareFusion Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Drive DeVilbiss Healthcare
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Fisher & Paykel Healthcare
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 PARI Respiratory Equipment
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Trudell Medical International
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Nebulizer Kit With Mouthpiece Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Nebulizer Kit With Mouthpiece market is categorized based on

Key Players

• Philips Healthcare
• Omron Healthcare
• Drive DeVilbiss Healthcare
• PARI Respiratory Equipment
• DeVilbiss Healthcare
• Medtronic
• Invacare Corporation
• Sunrise Medical
• Rudolf Riester GmbH
• Trudell Medical International
• Altera Health
• Welch Allyn
• Fisher & Paykel Healthcare
• CareFusion Corporation
• ResMed